Ortetamine 2-Methylamphetamine hydrochloride CAS: 77083-24-0

CAS NO: 77083-24-0
Ortetamine 2-Methylamphetamine hydrochloride
Chemical Name: o,α-DiMethylphenethylaMine Hydrochloride
Molecular Formula: C10H16ClN
Formula Weight: 185.69374
CAS No.: 77083-24-0
Description Review
Description

Ortetamine 2-Methylamphetamine hydrochloride (CAS: 77083-24-0) is a synthetic drug that is classified as a psychoactive stimulant. The drug is also known as 2-Methylamphetamine hydrochloride and is often used as a designer drug, marketed as a legal alternative to methamphetamine. However, it is important to note that Ortetamine 2-Methylamphetamine hydrochloride is not safe for human consumption and its use can lead to severe health problems.

Chemical name:

Ortetamine 2-Methylamphetamine hydrochloride is also known as 2-Methylamphetamine hydrochloride. Its chemical structure is C10H16ClN.

Molecular formula:

The molecular formula of Ortetamine 2-Methylamphetamine hydrochloride is C10H16ClN.

Formula weight:

The formula weight of Ortetamine 2-Methylamphetamine hydrochloride is 181.7 g/mol.

CAS No:

The CAS number of Ortetamine 2-Methylamphetamine hydrochloride is 77083-24-0.

Top ten keywords from Google and Synonyms:

  1. Ortetamine 2-Methylamphetamine hydrochloride: Also known as CAS: 77083-24-0.
  2. Psychoactive drug: A drug that affects the mind and behavior.
  3. Designer drug: A synthetic drug that is marketed as a legal alternative to illegal drugs.
  4. Stimulant: A drug that stimulates the nervous system and increases energy levels.
  5. Amphetamine: An organic compound that acts as a stimulant.
  6. Methamphetamine: A highly-addictive drug with stimulant effects.
  7. Addiction: Prolonged use of this drug can lead to addiction.
  8. CNS Stimulant: This drug acts as a central nervous system stimulant.
  9. Legal highs: Drugs marketed as legal alternatives to illegal substances.
  10. Party drug: A drug used for recreational purposes.

Health benefits of this product:

There are no known health benefits of Ortetamine 2-Methylamphetamine hydrochloride. The drug is not approved for any medical use and is not safe for human consumption.

Potential effects:

The potential effects of Ortetamine 2-Methylamphetamine hydrochloride are similar to other stimulants like amphetamine and methamphetamine. The drug can increase energy levels, induce euphoria, and enhance cognitive performance. However, it can also cause cardiovascular effects and lead to addiction.

Product mechanism:

Ortetamine 2-Methylamphetamine hydrochloride acts on the central nervous system, specifically on the monoamine neurotransmitter system. It increases the levels of dopamine, norepinephrine, and serotonin in the brain, inducing the stimulant effects. However, the drug has not been extensively studied and its mechanism of action is not well understood.

Safety:

Ortetamine 2-Methylamphetamine hydrochloride is not safe for human consumption. The drug has not been approved by any medical organization and is considered a designer drug. Its use can cause addiction, cardiovascular effects, and long-term health problems. Overdose can result in coma or death.

Side effects:

The side effects of Ortetamine 2-Methylamphetamine hydrochloride can vary widely depending on the dose and other factors. Common side effects include nausea, vomiting, insomnia, and hypertension. Prolonged use of the drug can lead to drug addiction and long-term health problems.

Dosing information:

There is no safe dosage information available for Ortetamine 2-Methylamphetamine hydrochloride. The drug is not approved for human consumption and its use is illegal. Dosing information is not available as there is no safe medical use for this drug.

Conclusion:

Ortetamine 2-Methylamphetamine hydrochloride is a designer drug that is not safe for human use. It is marketed as a legal alternative to methamphetamine, but its use can lead to severe health problems. The drug acts on the central nervous system, increasing the levels of dopamine, norepinephrine, and serotonin in the brain. Its use can cause addiction, cardiovascular effects, and long-term health problems. There are no safe dosing recommendations or health benefits associated with this drug. It is important to note that Ortetamine 2-Methylamphetamine hydrochloride is illegal and its use can lead to legal consequences.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code